# Azurite Microorganisms

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/azurite-microorganisms

- Industry: Biotechnology
- Headquarters: Beijing, China
- Website: www.bluepha.com/
- Total disclosed funding: $66M
- Latest round: Series B (Aug 9, 2021)
- Investors on record: 5

## About

Based in China, and founded in 2016 by its CEO Dr. Zhang Haoqian and co-founder Dr.Li Teng, Azurite Microorganisms trading as Bluepha operates as an enterprise engaged in molecular and material innovation based on synthetic biotechnology. In January 2022, Azurite Microorganisms raised an undisclosed amount of venture funding co-led by new investors Blue Ocean Capital, ZhongPing Capital, and Jiangsu Yellow Sea, with participation from returning investors Country Garden, Hillhouse Capital Group, Peak, and Sany Group Co. Ltd.

Azurite Microorganisms is dedicated to the design, development, manufacture, and sales of new bio-based molecules and materials, helping B-end customers in many industries, such as consumer goods, food, medical, agriculture, and industry.

The company will use the venture funding for the construction and operation of large-scale production facilities for biodegradable materials PHA, industrial and in the development and deployment of the 4.0 synthetic biology research and development platform SynBio_OS, as well as the research and development of new product pipelines such as regenerative medicine materials and engineered probiotic.

## Funding rounds

- Series B, Aug 9, 2021, $66M — Lightspeed Venture Partners, Taihe Capital, Shenzhen Country Garden Venture Capital Co., Ltd., Hongxi Investment, Fangyuan Capital (Hong Kong) Limited

## Investors

- Lightspeed Venture Partners (https://capitalatlas.ai/funds/lightspeed-venture-partners) — Series B
- Taihe Capital — Series B
- Shenzhen Country Garden Venture Capital Co., Ltd. — Series B
- Hongxi Investment — Series B
- Fangyuan Capital (Hong Kong) Limited (https://capitalatlas.ai/funds/fangyuan-capital-hong-kong-limited) — Series B